The results showed that the β-catenin and NF-κB recognition based gene circuit worked in bladder cancer cells, and that expression of CD3-scFv driven by the gene circuit could induce T cells to kill tumor cells effectively. The gene discussed is NFKB1; the disease is urinary bladder carcinoma.